IMJUDO vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. IMJUDO and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IMJUDO	TECENTRIQ
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TREMELIMUMAB-ACTL	ATEZOLIZUMAB
Manufacturer	Astrazeneca Ab	Genentech Inc
Dosage forms	Injectable	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Hepatocellular Carcinoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

imjudo tecentriq

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

TREMELIMUMAB-ACTL

ATEZOLIZUMAB

Manufacturer

Astrazeneca Ab

Genentech Inc

Dosage forms

Injectable

Drug class

—

Boxed warning

None

Treats

Hepatocellular Carcinoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

What is the difference between Imjudo and Tecentriq?

Imjudo contains Tremelimumab-Actl, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.